PFE - Pfizer Inc.

NYSE - NYSE Delayed price. Currency in USD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
50,660,000
51,750,000
53,647,000
52,546,000
52,824,000
Cost of revenue
10,164,000
10,219,000
11,248,000
11,240,000
12,329,000
Gross profit
40,496,000
41,531,000
42,399,000
41,306,000
40,495,000
Operating expenses
Research development
8,671,000
8,650,000
8,006,000
7,657,000
7,872,000
Selling general and administrative
13,884,000
14,350,000
14,455,000
14,784,000
14,837,000
Total operating expenses
26,867,000
27,610,000
27,354,000
27,199,000
26,765,000
Operating income or loss
13,629,000
13,921,000
15,045,000
14,107,000
13,730,000
Interest expense
1,603,000
1,574,000
1,316,000
1,270,000
1,186,000
Total other income/expenses net
5,022,000
5,108,000
-2,178,000
-923,000
-4,663,000
Income before tax
17,244,000
17,682,000
11,885,000
12,305,000
8,351,000
Income tax expense
1,426,000
1,384,000
706,000
-9,049,000
1,123,000
Income from continuing operations
15,819,000
16,298,000
11,179,000
21,353,000
7,229,000
Net income
15,790,000
16,273,000
11,153,000
21,308,000
7,215,000
Net income available to common shareholders
15,790,000
16,272,000
11,152,000
21,307,000
7,214,000
Basic EPS
-
2.92
1.90
3.57
1.18
Diluted EPS
-
2.87
1.87
3.52
1.17
Basic average shares
-
5,569,000
5,872,000
5,970,000
6,089,000
Diluted average shares
-
5,675,000
5,977,000
6,058,000
6,159,000
EBITDA
-
25,266,000
19,585,000
19,844,000
15,294,000